# Ultrahypofractionated Whole Breast Radiation Following Chemotherapy

> **NCT06664892** · NA · NOT_YET_RECRUITING · sponsor: **MetroHealth Medical Center** · enrollment: 213 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Ultra-hypofractionated radiation

## Key facts

- **NCT ID:** NCT06664892
- **Lead sponsor:** MetroHealth Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664892, "Ultrahypofractionated Whole Breast Radiation Following Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06664892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*